Karl Baldacchino

PhD in Precision Medicine student (University of Edinburgh) researching OPC remyelination in MS in the Williams & Czopka labs 🧠

[Karl Baldacchino @Karlbino]

Exciting day at #SULSAIndAc25 conference - some great talks so far and looking forward to the rest!

[Karl Baldacchino @Karlbino]

Very proud to have been awarded the Sir Ian Wilmut prize for my work looking at OPC dysfunction in Multiple Sclerosis. Thank you to the panel and the organisers of the @EdinUni_IRR Away Day!

[Karl Baldacchino @Karlbino]

Recently had the amazing opportunity to present my PhD research at the @UKDRI Macroglia meeting in York and was awarded the ECR Talk prize - thank you to the organisers & everyone involved! #ECR #PhD #AcademicTwitter

[Rebecca Smith, PhD @RebeccaSmithPhD]

Come see our PhD student @Karlbino at the #edneuroday Poster number @AnnaWilliamsLab ‘Why don’t spinal cord OPCs remyelinate well in Multiple sclerosis and how do we fix it?’

[Karl Baldacchino @Karlbino]

Always important to have friends who’ll take candids while you present your PhD project👨🏻‍🔬🧠🐟 #PhD #AcademicChatter #AcademicTwitter

[Karl Baldacchino @Karlbino]

Two excellent supervisors and a highly interesting project - I highly recommend to anyone interested!

[Tim Czopka Lab @Czopka_Lab]

PhD project available in our group together with ⁦@AnnaWilliamsLab⁩. The title pretty much gives it away…
Lots to learn and lots to discover! https://t.co/mstIt2Vr1A

[Rebecca Smith, PhD @RebeccaSmithPhD]

The Williams Lab group photo - in the style of Keeping up with the Kardashians✨ (CRM Retreat 2023)🔬🧫🧠

[Karl Baldacchino @Karlbino]

Exciting day ahead at the #NCMS2023 annual meeting - a great opportunity to hear about clinical work on #MS

[Lukas Valihrach @LukasValihrach]

Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer’s disease🧠 https://t.co/TyLAU8bNYy

[Karl Baldacchino @Karlbino]

An insightful paper which sheds some much needed light on regional differences in glia! Excited to have the opportunity to build on Luise’s work and focus on transcriptomic differences in OPCs in my PhD project #glia #MS

[Luise Seeker @LuiseASeeker]

1/11
Paper alert. Human glia vary more with CNS region than with age and sex. Our new paper is out today and this is a 🧵 summarising some key results.
https://t.co/xK1oMy1Tqr

[kellie 🌻��‍🔬 @kellie_horan_]

Tickets for @pintofscience go on sale today! ✨ Come see some amazing science talks across 6 themes in pubs and venues in Edinburgh 🏴󠁧󠁢󠁳󠁣󠁴󠁿 buy your tickets now at: https://t.co/LoUKfgrqcG
#pint23 🍻

[Karl Baldacchino @Karlbino]

Excellent opportunities to join us at the Williams lab - come for the groundbreaking research; stay for the lab meeting pastries! 🥐

[Karl Baldacchino @Karlbino]

@TepavcevicVanja This is something I’m planning to look into in the coming weeks! But we expect to find less and are hoping to be able to quantify this using a PDGFRA probe. I also want to say thank you for the excellent review paper published last December - really insightful!

[Karl Baldacchino @Karlbino]

Had the amazing opportunity of presenting a poster at this year’s #EdNeuroDay where I presented the current findings of my PhD study titled ‘Why don’t spinal cord OPCs remyelinate well in MS and how do we fix it?’ #AcademicTwitter #phdchat

[Karl Baldacchino @Karlbino]

Thank you to everyone who has been involved in this project so far, namely everyone within the @AnnaWilliamsLab and @Czopka_Lab, and specifically @LuiseASeeker for all her help so far!

[Karl Baldacchino @Karlbino]

One of my favourite things about living in Scotland is getting to write in this atmosphere #phdchat #AcademicTwitter

[Lukas Valihrach @LukasValihrach]

Interested in #heterogeneity of #oligodendrocyte? Are you analyzing #scRNAseq and need fast #understanding of #OL biology?
👇Check our #review!👇
You find #key #publications and #markers of #OL #populations existing in health and disease (#MS #AD).. 🧵https://t.co/kNluClIL9w

[Karl Baldacchino @Karlbino]

@ThePhDPlace Please just remyelinate

[UofG Sii @UofGSii]

🆕 | Research by @iiiGlasgow scientists has shown for the first time that iron overload can contribute to the ongoing brain damage in progressive MS, confirming treatments preventing this could slow accumulation of disability.

🔗https://t.co/saathOLmtn

📜https://t.co/FdbB928HqG